These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37956676)

  • 21. Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma.
    Gavine PR; Wang M; Yu D; Hu E; Huang C; Xia J; Su X; Fan J; Zhang T; Ye Q; Zheng L; Zhu G; Qian Z; Luo Q; Hou YY; Ji Q
    BMC Cancer; 2015 Jun; 15():454. PubMed ID: 26040563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Phytochemicals Targeting c-Met Kinase Domain using Consensus Docking and Molecular Dynamics Simulation Studies.
    Aliebrahimi S; Montasser Kouhsari S; Ostad SN; Arab SS; Karami L
    Cell Biochem Biophys; 2018 Jun; 76(1-2):135-145. PubMed ID: 28852971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of high-affinity inhibitors of pyruvate dehydrogenase kinase-3: towards therapeutic management of cancer.
    Mohammad T; Arif K; Alajmi MF; Hussain A; Islam A; Rehman MT; Hassan I
    J Biomol Struct Dyn; 2021 Feb; 39(2):586-594. PubMed ID: 31903847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of novel CDK 9 inhibitors based on virtual screening, molecular dynamics simulation, and biological evaluation.
    Wu M; Han J; Liu Z; Zhang Y; Huang C; Li J; Li Z
    Life Sci; 2020 Oct; 258():118228. PubMed ID: 32781071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of High-Affinity Inhibitors of TANK-Binding Kinase 1 (TBK1): A Promising Frontier for Controlling Inflammatory Signaling in Cancer.
    Jairajpuri DS; Mohammad T; Hussain A; Alajmi MF; Yadav DK; Hassan MI
    Discov Med; 2024 Jan; 36(180):129-139. PubMed ID: 38273753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase.
    Shukla R; Shukla H; Sonkar A; Pandey T; Tripathi T
    J Biomol Struct Dyn; 2018 Jun; 36(8):2045-2057. PubMed ID: 28605994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated virtual screening and MD simulation study to discover potential inhibitors of Lyn-kinase: targeting cancer therapy.
    Hassan MI; Anjum D; Mohammad T; Alam M; Khan MS; Shahwan M; Shamsi A; Yadav DK
    J Biomol Struct Dyn; 2023 Dec; 41(20):10558-10568. PubMed ID: 36495308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting Cytotoxin-Associated Antigen A, a Virulent Factor of
    He S; Almalki AA; Rafeeq MM; Sain ZM; Alqosaibi AI; Alnamshan MM; Al-Dhuayan IS; Rahaman A; Zhang Y; Banjer HJ; Anjum F; Alzghaibi HAM; Alharbi AH; Jamal QMS
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
    Iqbal S; Anantha Krishnan D; Gunasekaran K
    J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of the hot spot residues for pyridine derivative inhibitor CCT251455 and ATP substrate binding on monopolar spindle 1 (MPS1) kinase by molecular dynamic simulation.
    Chen K; Duan W; Han Q; Sun X; Li W; Hu S; Wan J; Wu J; Ge Y; Liu D
    J Biomol Struct Dyn; 2019 Feb; 37(3):611-622. PubMed ID: 29380674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of Natural Compounds as Potential Inhibitors of Human Carbonic Anhydrase II: An Integrated Virtual Screening, Docking, and Molecular Dynamics Simulation Study.
    Anjum F; Ali F; Mohammad T; Shafie A; Akhtar O; Abdullaev B; Hassan I
    OMICS; 2021 Aug; 25(8):513-524. PubMed ID: 34255561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of 11-Hydroxytephrosin and Torosaflavone A as Potential Inhibitors of 3-Phosphoinositide-Dependent Protein Kinase 1 (PDPK1): Toward Anticancer Drug Discovery.
    Atiya A; Alhumaydhi FA; Sharaf SE; Al Abdulmonem W; Elasbali AM; Al Enazi MM; Shamsi A; Jawaid T; Alghamdi BS; Hashem AM; Ashraf GM; Shahwan M
    Biology (Basel); 2022 Aug; 11(8):. PubMed ID: 36009858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioactive Phytoconstituents as Potent Inhibitors of Tyrosine-Protein Kinase Yes (YES1): Implications in Anticancer Therapeutics.
    Yang C; Alam A; Alhumaydhi FA; Khan MS; Alsagaby SA; Al Abdulmonem W; Hassan MI; Shamsi A; Bano B; Yadav DK
    Molecules; 2022 May; 27(10):. PubMed ID: 35630545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of potential JNK3 inhibitors through virtual screening, molecular docking and molecular dynamics simulation as therapeutics for Alzheimer's disease.
    Devi B; Jangid K; Kumar N; Kumar V; Kumar V
    Mol Divers; 2024 Apr; ():. PubMed ID: 38573427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combining ligand- and structure-based in silico methods for the identification of natural product-based inhibitors of Akt1.
    Mahajan P; Wadhwa B; Barik MR; Malik F; Nargotra A
    Mol Divers; 2020 Feb; 24(1):45-60. PubMed ID: 30798436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Four New Chemical Series of Small Drug-Like Natural Products as Potential Neuropilin-1 Inhibitors by Structure-Based Virtual Screening: Pharmacophore-Based Molecular Docking and Dynamics Simulation.
    Sabki A; Khelifi L; Kameli A; Baali S
    Chem Biodivers; 2023 Mar; 20(3):e202200933. PubMed ID: 36799050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of potential inhibitors of Fasciola gigantica thioredoxin1: computational screening, molecular dynamics simulation, and binding free energy studies.
    Shukla R; Shukla H; Kalita P; Sonkar A; Pandey T; Singh DB; Kumar A; Tripathi T
    J Biomol Struct Dyn; 2018 Jun; 36(8):2147-2162. PubMed ID: 28627969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of novel FAK and S6K1 dual inhibitors from natural compounds via ADMET screening and molecular docking.
    Thiyagarajan V; Lin SH; Chang YC; Weng CF
    Biomed Pharmacother; 2016 May; 80():52-62. PubMed ID: 27133039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-based virtual screening and molecular dynamics simulations for detecting novel candidates for allosteric inhibition of EGFRT790M.
    Çoban G
    J Biomol Struct Dyn; 2024; 42(2):571-597. PubMed ID: 37029759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DFT, molecular docking and molecular dynamics simulation studies on some recent natural products revealing their EGFR tyrosine kinase inhibition potential.
    Erdogan T; Oguz Erdogan F
    J Biomol Struct Dyn; 2024 Apr; 42(6):2942-2956. PubMed ID: 37144731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.